Phase II study of erlotinib for previously treated patients...

  • Main
  • 2014 / 07
  • Phase II study of erlotinib for previously treated patients...

Phase II study of erlotinib for previously treated patients with EGFR wild‑type non‑small‑cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System

Morise, Masahiro, Taniguchi, Hiroyuki, Saka, Hideo, Shindoh, Joe, Suzuki, Ryujiro, Kojima, Eiji, Hase, Tetsunari, Ando, Masahiko, Kondo, Masashi, Saito, Hiroshi, Hasegawa, Yoshinori
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2014.354
Date:
July, 2014
File:
PDF, 298 KB
english, 2014
Conversion to is in progress
Conversion to is failed